Posted on: 05 September, 2019
Congratulations to Professor David Hunter who’s received a prestigious University of Sydney Vice Chancellor’s award for outstanding research.
The Kolling researcher and rheumatology clinician is regarded as the world’s leading expert in osteoarthritis.
Professor Hunter’s research has had a significant and lasting impact in the field of osteoarthritis, influencing clinical practice and access to ev.....
Read more
Category: Awards, New Treatment
Posted on: 28 August, 2019
More than 40 per cent of people injured in a traffic accident are psychologically distressed one month after their accident, with many of those suffering depression and post-traumatic stress symptoms.
The research forms part of the latest findings into the physical and emotional impact of motor vehicle crash injuries by the team from the John Walsh Centre for Rehabilitation Research.
From left to r.....
Read more
Category: Research Excellence
Posted on: 23 August, 2019
Kolling Institute cancer researchers were given an opportunity to spend the day with presenter Julie McCrossin.
Julie spent more than 20 years as a radio broadcaster and is now a freelance journalist, facilitator, trainer and speaker. Julie invests a large share of her time supporting research initiatives, and in recent years has received treatment for head and neck cancer.
Julie delivered an impr.....
Read more
Category: Presentations
Posted on: 09 August, 2019
Two Kolling Institute researchers have welcomed a significant funding boost through a large NSW Government program to help tackle Australia’s number one killer, heart disease.
Professors Gemma Figtree and Martin Ugander have each been awarded a $750,000 grant to encourage researchers to find breakthroughs and help establish NSW as a centre for research excellence.
The funding is part of a broader .....
Read more
Category: Funding support
Posted on: 22 July, 2019
The latest exciting research into musculoskeletal disease has been unveiled during the inaugural Northern Lights showcase.
Close to 200 people attended the jam packed event in the Kolling auditorium, including clinicians, researchers and many people living with arthritic pain.
RNSH Head of Rheumatology Professor Lyn March addressed the event, detailing the devastating cost of the disease to indivi.....
Read more
Category: New Treatment
Posted on: 12 June, 2019
The Kolling’s Director of Research Professor Carolyn Sue has been awarded a Member of the Order of Australia (AM) in this year’s Queen’s Birthday Honours for her significant service to medicine, particularly mitochondrial disease.
Carolyn is a highly accomplished neurologist and is internationally regarded for her work in both Parkinson’s and mitochondrial disease.
Recently appointed to the Directo.....
Read more
Posted on: 12 June, 2019
Research capabilities within the Kolling Institute have been significantly broadened with new technology to assist the examination of bowel cancer.
Representatives from Sydney University, the Kolling and Bowel Cancer Australia attended the official opening of the mass spectrometry core lab – the first of its type on a hospital campus and one of the best analytical facilities in the world.
Professo.....
Read more
Category: World-leading technology, New Treatment